Skip to main content

Calendar

To view more alumni events, click here.

Apr
8
Wed
E2SHI’s Annual Symposium: Innovations in Managing Climate Risk
Apr 8 @ 12:00 pm – 1:30 pm

The Johns Hopkins Environment, Energy, Sustainability & Health Institute (E²SHI) invites you to an interactive session led by Pablo Suarez from the Red Cross/Red Crescent Climate Centre on climate change and disaster response, and to explore how to bridge science, policy and practice. The title of the presentation is “Innovations in Managing Climate Risk: Reimagining humanitarian and development work.”

Pablo SuarezA light lunch will be served starting at 11:45 am, and Michael Klag, Dean of the Bloomberg School of Public Health, will give opening remarks.

The symposium is free and open to all Johns Hopkins faculty, staff and students, as well as community members.

RSVP by April 5 to attend.

Details here.

Feb
24
Fri
OSA/EDGE presents “Transition from Academia to Industry”
Feb 24 @ 12:00 pm – 1:00 pm

Tzu-Yu Wu, an optical engineer at Canon USA’s Healthcare Optics Research Laboratory, will speak about the “Transition from Academia to Industry.” Registration required. Hosted by BME Edge.

Apr
14
Fri
Canceled – Robert Nerem presents “Regenerative Medicine: The Hype, the Hope, and the Future”
Apr 14 @ 3:30 pm – 4:30 pm
Canceled - Robert Nerem presents "Regenerative Medicine: The Hype, the Hope, and the Future" @ 26 Mudd Hall

This event has been canceled.

Robert M. Nerem (Georgia Institute of Technology) presents “Regenerative Medicine: The Hype, the Hope, and the Future” as part of a special seminar hosted by the Department of Biomedical Engineering, the Institute for NanoBioTechnology, and the Translational Tissue Engineering Center.

Abstract: Although the underlying concepts of tissue engineering and regenerative medicine go back more than 75 years, the term tissue engineering actually was only “coined” in the 1980s. This was followed by the 1990s being the “go-go” years with stem cells emerging as a technology, an industry developing, and the term regenerative medicine beginning to be used. There also was a lot of hype, and following the turn of the century the field entered what might be called the “sobering” years, with private sector activity falling significantly even though the science continued to advance. The last decade, however, has all the marks of being “back to the future.” Advances in cell-based therapies have been fueled by advances in stem cell science and technology and the discovery of what is required to reprogram somatic cells into stem cells, known as induced pluripotent stem (iPS) cells. For cellular therapies, a key question is what is the mechanism of action? For a specific therapy, is the mechanism one of cell replacement or is it a paracrine effect? If the latter, is it possible that one could introduce the appropriate biological signals without the use of cells? In this case the discussion shifts from “my cell is better than your cell” to “my biological signals are better than yours.” Whatever the case, one of the “holy grails” is the neurodegenerative diseases/disorders and the repair/regeneration of the central nervous system. Instead of the mixture of hype and hope in the past, and with an aging population providing the threat of a “tsunami” of neural disorders, regenerative medicine offers the real possibility of cures to these diseases/disorders in the future.

Back to top